Results 281 to 290 of about 13,250,277 (360)
Apolipoprotein B Subspecies of VLDL in Primary Hyperlipoproteinemia and Diabetes Mellitus
Hirotada Takai+6 more
openalex +2 more sources
Lipids, apolipoproteins, carbohydrates, and risk of hematological malignancies. [PDF]
Liu Q+8 more
europepmc +1 more source
ABSTRACT Purpose Diabetes mellitus (DM) is a major cause of end‐stage kidney disease (ESKD), with kidney transplantation being the preferred treatment. However, post‐transplant diabetes mellitus (PTDM) increases mortality and graft loss. While PTDM and Type 2 diabetes mellitus (T2DM) share risk factors, their mechanisms differ, particularly in diabetic
Eleni Skandalou+7 more
wiley +1 more source
Effects of phytosterol supplementation on lipid profiles and apolipoproteins: A meta-analysis of randomized controlled trials. [PDF]
Zhang YF+6 more
europepmc +1 more source
Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women. [PDF]
Zhu L+7 more
europepmc +1 more source
Porcine Sub-Retinal Pigment Epithelium Deposits: A Model for Dry Age-Related Macular Degeneration With Comparison to Human Drusen. [PDF]
Shaw EM+5 more
europepmc +1 more source
Divergent Roles of APOAI and APOM in the Identification of Alcohol Use Disorder and Their Association With Inflammation and Cognitive Decline: A Pilot Study. [PDF]
Escudero B+3 more
europepmc +1 more source
ABSTRACT Evinacumab, an angiopoietin‐like 3 (ANGPTL3) inhibitor, significantly reduces low‐density lipoprotein cholesterol (LDL‐C), independent of low‐density lipoprotein receptor, in patients with homozygous familial hypercholesterolemia (HoFH). A population pharmacokinetic (PK)/pharmacodynamic (PD) model was previously developed to characterize ...
Sébastien Bihorel+8 more
wiley +1 more source